文献速递慢性肾脏病

健康人群与慢性肾脏病患者的血浆精氨酸代谢物

Plasma arginine metabolites in health and chronic kidney disease.
PubMed 文献 · Nephrol Dial Transplant · 2023-01-01

在Dunedin多学科健康与发展研究(DMHDS)45岁队列中,采用液相色谱-串联质谱测定血浆ADMA、SDMA、L-精氨酸和L-瓜氨酸。总队列(n=857)中SDMA与血清肌酐和血浆胱抑素C正相关、与eGFR负相关;38例3-4期CKD患者ADMA、SDMA和L-瓜氨酸均值显著更高;ADMA和SDMA可预测肾脏健康不良结局高风险,联合AUC为0.90。

要点

  • 总队列(n=857)中SDMA与血清肌酐(r=0.55)和血浆胱抑素C(r=0.55)正相关,与eGFR负相关(r=0.52)。
  • 38例3-4期CKD患者ADMA(0.61±0.11 µmol/L)、SDMA(0.65±0.25 µmol/L)和L-瓜氨酸(42.7±11.8 µmol/L)均值显著高于健康亚组。
  • ADMA和SDMA单独预测肾脏健康不良结局高风险的AUC分别为0.83和0.84,联合AUC为0.90。

核心结论

  • 血浆甲基精氨酸浓度有助于对CKD进展风险进行分层。

研究设计与样本

  • 在DMHDS队列45岁成员中,采用液相色谱-串联质谱测定血浆ADMA、SDMA、L-精氨酸和L-瓜氨酸。
  • 健康DMHDS亚组n=376,总队列n=857,另设38例3-4期CKD(eGFR 15-60 mL/min/1.73 m2)患者队列。

主要发现

  • 健康DMHDS亚组(n=376)均值:ADMA 0.40±0.06 µmol/L,SDMA 0.42±0.06 µmol/L,L-精氨酸93.5±23.1 µmol/L,L-瓜氨酸24.0±5.4 µmol/L。
  • 总队列(n=857)中SDMA与血清肌酐正相关(Pearson r=0.55),与血浆胱抑素C正相关(r=0.55),与eGFR负相关(r=0.52)。
  • 38例3-4期CKD患者均值:ADMA 0.61±0.11 µmol/L,SDMA 0.65±0.25 µmol/L,L-瓜氨酸42.7±11.8 µmol/L,显著高于健康亚组。
  • DMHDS中肾脏健康不良结局高风险成员四种代谢物均值均显著高于非高风险个体。
  • ADMA和SDMA单独预测肾脏健康不良结局高风险的AUC分别为0.83和0.84,联合AUC为0.90。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Elevated plasma asymmetric and symmetric dimethylarginine (ADMA and SDMA) are risk factors for chronic kidney disease (CKD) and cardiovascular disease. Using plasma cystatin C (pCYSC)-based estimated glomerular filtration rate (eGFR) trajectories, we identified a cohort at high risk of poor kidney-related health outcomes amongst members of the Dunedin Multidisciplinary Health and Development Study (DMHDS). We therefore examined associations between methylarginine metabolites and kidney function in this cohort. METHODS: ADMA, SDMA, L-arginine and L-citrulline were measured in plasma samples from 45-year-olds in the DMHDS cohort by liquid chromatography-tandem mass spectrometry. RESULTS: In a healthy DMHDS subset (n = 376), mean concentrations were: ADMA (0.40 ± 0.06 µmol/L), SDMA (0.42 ± 0.06 µmol/L), L-arginine (93.5 ± 23.1 µmol/L) and L-citrulline (24.0 ± 5.4 µmol/L). In the total cohort (n = 857), SDMA correlated positively with serum creatinine (Pearson's r = 0.55) and pCYSC (r = 0.55), and negatively with eGFR (r = 0.52). A separate cohort of 38 patients with stage 3-4 CKD (eGFR 15-60 mL/min/1.73 m2) confirmed significantly higher mean ADMA (0.61 ± 0.11 µmol/L), SDMA (0.65 ± 0.25 µmol/L) and L-citrulline (42.7 ± 11.8 µmol/L) concentrations. DMHDS members classified as high-risk of poor kidney health outcomes had significantly higher mean concentrations of all four metabolites compared with individuals not at risk. ADMA and SDMA individually predicted high-risk of poor kidney health outcomes with areas under the ROC curves (AUCs) of 0.83 and 0.84, and together with an AUC of 0.90. CONCLUSIONS: Plasma methylarginine concentrations facilitate stratification for risk of CKD progression.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Au AYM, Mantik K, Bahadory F, et al. Plasma arginine metabolites in health and chronic kidney disease. Nephrol Dial Transplant. 2023. PMID: 37230955. doi:10.1093/ndt/gfad108

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。